Type 2 diabetes mellitus
Suitable for initiation in primary care in line with restrictions (see background paragraph)
Lixisenatide is not a preferred product in the LSCMMG antihyperglycaemics guideline.
Lixisenatide recommended as an option in line with NICE guideline NG28.
Reason for decision:
Suitable for initiation in primary care